Bracco Imaging Announces Strategic Investment in PHS Technologies Group
By MedImaging International staff writers Posted on 05 Apr 2017 |
Bracco Imaging S.p.A., which develops, manufactures and markets diagnostic imaging agents and solutions, has announced a strategic investment in PHS Technologies Group, LLC, which is a division of PACSHealth, LLC, a medical software development company.
Bracco’s product and solution portfolio comprises all key diagnostic imaging modalities, along with various medical devices and advanced administration systems for contrast imaging products in the fields of radiology. PHS Technologies Group offers advanced solutions that enable hospitals to manage patient radiation exposure and comply with regulatory requirements and industry guidelines, while increasing efficiency and reducing cost.
Bracco’s strategic investment in PHS Technologies Group aims at expanding its portfolio of software applications for dose management to provide healthcare organizations with the information required to ensure patient safety, enhance imaging exam consistency, maintain regulatory compliance and monitor radiation dose at an enterprise level. The agreement also strengthens the partnership with PHS Technologies Group, allowing Bracco to enhance distribution efforts of NEXO[DOSE], a software application for automated patient radiation exposure data aggregation and reporting from multiple x-ray modalities.
"We are pleased to reinforce our partnership with PHS Technologies," said Fulvio Renoldi Bracco, Head of the Business Unit Imaging at Bracco Imaging. "The investment will provide new opportunities for Bracco to quickly address the increasing challenges in healthcare delivery according to the new market requirements in terms of radiation exposure monitoring."
"PHS Technologies Group is excited to expand its relationship with Bracco," said Mike Battin, Chief Operating Officer of PHS Technologies Group. "PHS is the OEM manufacturer for Bracco's NEXO[DOSE] product and will implement an expanded service and support offerings to the new markets. Furthermore, PHS will provide significant functional improvements to the application portfolio over the next 24 months."
Bracco’s product and solution portfolio comprises all key diagnostic imaging modalities, along with various medical devices and advanced administration systems for contrast imaging products in the fields of radiology. PHS Technologies Group offers advanced solutions that enable hospitals to manage patient radiation exposure and comply with regulatory requirements and industry guidelines, while increasing efficiency and reducing cost.
Bracco’s strategic investment in PHS Technologies Group aims at expanding its portfolio of software applications for dose management to provide healthcare organizations with the information required to ensure patient safety, enhance imaging exam consistency, maintain regulatory compliance and monitor radiation dose at an enterprise level. The agreement also strengthens the partnership with PHS Technologies Group, allowing Bracco to enhance distribution efforts of NEXO[DOSE], a software application for automated patient radiation exposure data aggregation and reporting from multiple x-ray modalities.
"We are pleased to reinforce our partnership with PHS Technologies," said Fulvio Renoldi Bracco, Head of the Business Unit Imaging at Bracco Imaging. "The investment will provide new opportunities for Bracco to quickly address the increasing challenges in healthcare delivery according to the new market requirements in terms of radiation exposure monitoring."
"PHS Technologies Group is excited to expand its relationship with Bracco," said Mike Battin, Chief Operating Officer of PHS Technologies Group. "PHS is the OEM manufacturer for Bracco's NEXO[DOSE] product and will implement an expanded service and support offerings to the new markets. Furthermore, PHS will provide significant functional improvements to the application portfolio over the next 24 months."
Latest Industry News News
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures